Implication of folate deficiency in CYP2U1 loss of function - Institut Pasteur Access content directly
Journal Articles Journal of Experimental Medicine Year : 2021

Implication of folate deficiency in CYP2U1 loss of function

1 ICM - Institut du Cerveau = Paris Brain Institute
2 Biologie mitochondriale – Mitochondrial biology
3 PARCC (UMR_S 970/ U970) - Paris-Centre de Recherche Cardiovasculaire
4 Universität zu Köln = University of Cologne
5 Institut de la Vision
6 Service de Neurologie [CHU Pitié-Salpêtrière]
7 SU - Sorbonne Université
8 Fayoum University
9 National Research Centre - NRC (EGYPT)
10 DCAC - Défaillance Cardiovasculaire Aiguë et Chronique
11 CHRU Nancy - Centre Hospitalier Régional Universitaire de Nancy
12 NGERE - Nutrition-Génétique et Exposition aux Risques Environnementaux
13 MMDN - Mécanismes moléculaires dans les démences neurodégénératives
14 CHU Bordeaux [Bordeaux]
15 UB - Université de Bordeaux
16 Service de Neuropédiatrie [CHU Trousseau]
17 UC San Diego - University of California [San Diego]
18 Service de Biochimie Métabolique [CHU Pitié-Salpêtrière]
19 IRCCS - Istituto di Ricovero e Cura a Carattere Scientifico
20 UNIL - Université de Lausanne = University of Lausanne
21 HCL - Hospices Civils de Lyon
22 EPHE - École Pratique des Hautes Études
23 Profilomic [Boulogne-Billancourt]
24 Max planck Institute for Biology of Ageing [Cologne]
25 LCBPT - UMR 8601 - Laboratoire de Chimie et de Biochimie Pharmacologiques et Toxicologiques
26 IRCCS - Istituti di Ricovero e Cura a Carattere Scientifico
27 IBGC - Institut de biochimie et génétique cellulaires
28 Max Planck Institute for Metabolism Research [Cologne, Allemagne]
29 Service de Génétique Cytogénétique et Embryologie [CHU Pitié-Salpêtrière]
Serge Picaud
Alexandra Durr


Hereditary spastic paraplegias are heterogeneous neurodegenerative disorders. Understanding of their pathogenic mechanisms remains sparse, and therapeutic options are lacking. We characterized a mouse model lacking the Cyp2u1 gene, loss of which is known to be involved in a complex form of these diseases in humans. We showed that this model partially recapitulated the clinical and biochemical phenotypes of patients. Using electron microscopy, lipidomic, and proteomic studies, we identified vitamin B2 as a substrate of the CYP2U1 enzyme, as well as coenzyme Q, neopterin, and IFN-α levels as putative biomarkers in mice and fluids obtained from the largest series of CYP2U1-mutated patients reported so far. We also confirmed brain calcifications as a potential biomarker in patients. Our results suggest that CYP2U1 deficiency disrupts mitochondrial function and impacts proper neurodevelopment, which could be prevented by folate supplementation in our mouse model, followed by a neurodegenerative process altering multiple neuronal and extraneuronal tissues.
Fichier principal
Vignette du fichier
JEM_20210846 (1).pdf (3.6 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-03349041 , version 1 (20-09-2021)


Attribution - NonCommercial - ShareAlike



Claire Pujol, Anne Legrand, Livia Parodi, Priscilla Thomas, Fanny Mochel, et al.. Implication of folate deficiency in CYP2U1 loss of function. Journal of Experimental Medicine, 2021, 218 (11), pp.e20210846. ⟨10.1084/jem.20210846⟩. ⟨pasteur-03349041⟩
106 View
164 Download



Gmail Facebook Twitter LinkedIn More